Aprotinin treatment against SARS‐CoV‐2: A randomized phase III study to evaluate the safety and efficacy of a pan‐protease inhibitor for moderate COVID‐19 von Redondo‐Calvo, Francisco Javier, Padín, Juan Fernando, Muñoz‐Rodríguez, José Ramón, Serrano‐Oviedo, Leticia, López‐Juárez, Pilar, Porras Leal, María Lourdes, González Gasca, Francisco Javier, Rodríguez Martínez, Marta, Pérez Serrano, Raúl, Sánchez Cadena, Abraham, Bejarano‐Ramírez, Natalia, Muñoz Hornero, Constanza, Barberá Farré, José Ramón, Domínguez‐Quesada, Inmaculada, Sepúlveda Berrocal, María A., Villegas Fernández‐Infantes, María  Dolores, Manrique Romo, María Isabel, Parra Comino, Ángel, Pérez‐Ortiz, José Manuel, Gómez‐Romero, Francisco Javier, García Pérez, AM, Palomino Muñoz, T, Espinosa Justo, I, Ventura López, P, Cosmen‐Sánchez, A, Martínez Manzanal, R, Asenjo Villamayor, A, Loras Gallego, C, Alcañiz Octavio, I, Palma Bermejo, N, Andrés Navarro, N, Lizcaino Lizcanino, A, Cano Llorente, V, Prado Narciso, R, Hoyos Mohedano, J, Moya Gómez, P, Bodoque‐Villar, R, Pulido‐Sánchez, G, Illescas Fernández‐Bermejo, MS, Martínez Alarcón, J

Volltext

SUN-LB291: The Oral Nutritional Supplements Prescription Does Not Guarantee the Patients Consumption: New Strategies to Improve Patient Adherence von Morato-Martinez, M, Bermejo, L.M, Lopez-Plaza, B, Valero-Perez, M, Palma-Milla, S, Pelegrina-Cortes, B, García-Vazquez, N, Gomez-Candela, C

Volltext